Maen Abdelrahim, MD, PhD, B Pharm

Research outputs

  1. 2020
  2. Renal Replacement Therapy in Patients With Stage IV Cancer Admitted to the Intensive Care Unit With Acute Kidney Injury at a Comprehensive Cancer Center Was Not Associated With Survival

    Abudayyeh, A., Song, J., Abdelrahim, M., Dahbour, I., Page, V. D., Zhou, S., Shen, C., Zhao, B., Pai, R. N., Amaram-Davila, J., Manzano, J. G., George, M. C., Yennu, S., Mandayam, S. A., Nates, J. L. & Moss, A. H., Jan 1 2020, In : American Journal of Hospice and Palliative Medicine.

    Research output: Contribution to journalArticle

  3. 2019
  4. Is Surgery-first Still a Reasonable Option in the Era of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer?

    Saharia, A., Potter, L. M., Baio, F., Elaileh, A., Mobley, C., Ghobrial, R. M., Abdelrahim, M. & Heyne, K., Dec 27 2019, In : American journal of clinical oncology.

    Research output: Contribution to journalArticle

  5. Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: An institutional experience and a systematic review of the literature (Journal for ImmunoTherapy of Cancer (2019) 7:106 DOI: 10.1186/s40425-019-0585-1)

    Abdel-Wahab, N., Safa, H., Abudayyeh, A., Johnson, D. H., Trinh, V. A., Zobniw, C. M., Lin, H., Wong, M. K., Abdelrahim, M., Gaber, A. O., Suarez-Almazor, M. E. & Diab, A., Jun 24 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 158.

    Research output: Contribution to journalComment/debate

  6. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: An institutional experience and a systematic review of the literature

    Abdel-Wahab, N., Safa, H., Abudayyeh, A., Johnson, D. H., Trinh, V. A., Zobniw, C. M., Lin, H., Wong, M. K., Abdelrahim, M., Gaber, A. O., Suarez-Almazor, M. E. & Diab, A., Apr 16 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 106.

    Research output: Contribution to journalArticle

  7. Primary cardiac angiosarcoma diagnosed in the first trimester of pregnancy

    Burns, E. A., Ahmed, A., Sunkara, A., Khan, U., Sharif, R., Abdelrahim, M., Reardon, M. J. & Trachtenberg, B. H., Apr 9 2019, In : ecancermedicalscience. 13, 922.

    Research output: Contribution to journalArticle

  8. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

    Mamlouk, O., Selamet, U., Machado, S., Abdelrahim, M., Glass, W. F., Tchakarov, A., Gaber, L., Lahoti, A., Workeneh, B., Chen, S., Lin, J., Abdel-Wahab, N., Tayar, J., Lu, H., Suarez-Almazor, M., Tannir, N., Yee, C., Diab, A. & Abudayyeh, A., Jan 6 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 2.

    Research output: Contribution to journalArticle

  9. Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis

    Strati, P., Abdelrahim, M., Selamet, U., Page, V. D., Pierce, S. A., Verstovsek, S. & Abudayyeh, A., Jan 1 2019, In : Annals of Hematology.

    Research output: Contribution to journalArticle

  10. 2018
  11. Specificity protein transcription factors and cancer: Opportunities for drug development

    Safe, S., Abbruzzese, J., Abdelrahim, M. & Hedrick, E., Jul 1 2018, In : Cancer Prevention Research. 11, 7, p. 371-381 11 p.

    Research output: Contribution to journalReview article

  12. Renal complications of primary myelofibrosis

    Strati, P., Glass, W. F., Abdelrahim, M., Selamet, U., Tchakarov, A., Workeneh, B. T., Verstovsek, S. & Abudayyeh, A., Jun 28 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

    Research output: Contribution to journalArticle

  13. 2017
  14. Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam

    Ertem, F. U., Zhang, W., Chang, K., Mohaiza Dashwood, W., Rajendran, P., Sun, D., Abudayyeh, A., Vilar, E., Abdelrahim, M. & Dashwood, R. H., Jan 15 2017, In : International Journal of Cancer. 140, 2, p. 460-468 9 p.

    Research output: Contribution to journalArticle

  15. 2016
  16. Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury

    Oliver, N., Luong, T., Tchakarov, A., Abdelrahim, M., Mulanovich, V. E., Kontoyiannis, D. P., Jones, R., Kebriaei, P., Samuels, J. A., Glass, J. W. & Abudayyeh, A., Oct 2016, In : Bone Marrow Transplantation. 51, 10, p. 1301-1304 4 p.

    Research output: Contribution to journalArticle

  17. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients

    Abudayyeh, A., Hamdi, A., Abdelrahim, M., Lin, H., Page, V. D., Rondon, G., Andersson, B. S., Afrough, A., Martinez, C. S., Tarrand, J. J., Kontoyiannis, D. P., Marin, D., Gaber, A. O., Oran, B., Chemaly, R. F., Ahmed, S., Abudayyeh, I., Olson, A., Jones, R., Popat, U. & 3 othersChamplin, R. E., Shpall, E. J. & Rezvani, K., 2016, (Accepted/In press) In : Transplant Infectious Disease.

    Research output: Contribution to journalArticle

  18. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients

    Abudayyeh, A., Hamdi, A., Lin, H., Abdelrahim, M., Rondon, G., Andersson, B. S., Afrough, A., Martinez, C. S., Tarrand, J. J., Kontoyiannis, D. P., Marin, D., Gaber, A. O., Salahudeen, A., Oran, B., Chemaly, R. F., Olson, A., Jones, R., Popat, U., Champlin, R. E., Shpall, E. J. & 2 othersWinkelmayer, W. C. & Rezvani, K., 2016, (Accepted/In press) In : American Journal of Transplantation.

    Research output: Contribution to journalArticle

  19. 2015
  20. Targeted Therapy in Solid Tumors: Colorectal Cancer

    Abdelrahim, M., Kopetz, S. & Menter, D. G., Oct 30 2015, Targeted Therapy in Translational Cancer Research. Wiley, p. 193-204 12 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  21. Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines

    Naing, A., Dalal, S., Abdelrahim, M., Wheler, J. J., Hess, K. C., Fu, S., Hong, D. S., Janku, F., Falchook, G. S., Ilustre, A., Ouyang, F. & Kurzrock, R., Oct 1 2015, In : Supportive Care in Cancer. 23, 9, p. 2649-2654 6 p.

    Research output: Contribution to journalArticle

  22. Obstructive renal disease in cancer patients

    Abudayyeh, A. & Abdelrahim, M., Aug 7 2015, Onconephrology: Cancer, Chemotherapy and the Kidney. Springer New York, p. 309-317 9 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  23. Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib

    Rajasekaran, A., Ngo, T-T., Abdelrahim, M., Glass, W., Podoll, A., Verstovsek, S. & Abudayyeh, A., Aug 1 2015, In : BMC Nephrology. 16, p. 121

    Research output: Contribution to journalArticle

  24. Current Strategies for Prevention and Management of Stem Cell Transplant-Related Urinary Tract and Voiding Dysfunction

    Abudayyeh, A. & Abdelrahim, M., Jun 1 2015, In : Current Bladder Dysfunction Reports. 10, 2, p. 109-117 9 p.

    Research output: Contribution to journalReview article

  25. Membranous nephropathy in autologous hematopoietic stem cell transplant: Autologous graft-versus-host disease or autoimmunity induction?

    Abudayyeh, A., Truong, L. D., Beck, L. H., Weber, D. M., Rezvani, K. & Abdelrahim, M., 2015, In : Clinical Kidney Journal. 8, 4, p. 440-444 5 p.

    Research output: Contribution to journalArticle

  26. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma

    Hedrick, E., Lee, S-O., Kim, G., Abdelrahim, M., Jin, U-H., Safe, S. H. & Abudayyeh, A., 2015, In : PLoS ONE. 10, 6, p. e0128308

    Research output: Contribution to journalArticle

  27. Phase i trial of valproic acid and lenalidomide in patients with advanced cancer

    Bilen, M. A., Fu, S., Falchook, G. S., Ng, C. S., Wheler, J. J., Abdelrahim, M., Erguvan-Dogan, B., Hong, D. S., Tsimberidou, A. M., Kurzrock, R. & Naing, A., 2015, In : Cancer Chemotherapy and Pharmacology. 75, 4, p. 869-874 6 p.

    Research output: Contribution to journalArticle

  28. 2013
  29. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors

    Nair, V., Pathi, S., Jutooru, I., Sreevalsan, S., Basha, R., Abdelrahim, M., Samudio, I. & Safe, S. H., Dec 2013, In : Carcinogenesis. 34, 12, p. 2870-2879 10 p.

    Research output: Contribution to journalArticle

  30. TAS-106: Preclinical, clinical and beyond

    Abdelrahim, M., Matsuda, A. & Naing, A., Dec 2013, In : Oncology. 85, 6, p. 356-363 8 p.

    Research output: Contribution to journalReview article

  31. Fluid and Electrolyte Abnormalities in Patients with Cancer

    Abudayyeh, A., Abdelrahim, M. & Salahudeen, A., Oct 2013, Renal Disease in Cancer Patients. Elsevier, p. 167-182 16 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  32. 2012
  33. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer

    Sankpal, U. T., Abdelrahim, M., Connelly, S. F., Lee, C. M., Madero-Visbal, R., Colon, J., Smith, J., Safe, S. H., Maliakal, P. & Basha, R., Nov 2012, In : Prostate. 72, 15, p. 1648-1658 11 p.

    Research output: Contribution to journalArticle

  34. Environmental factors in causing human cancers: Emphasis on tumorigenesis

    Sankpal, U. T., Pius, H., Khan, M., Shukoor, M. I., Maliakal, P., Lee, C. M., Abdelrahim, M., Connelly, S. F. & Basha, R., Oct 2012, In : Tumor Biology. 33, 5, p. 1265-1274 10 p.

    Research output: Contribution to journalReview article

  35. Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats

    Maliakal, P., Abdelrahim, M., Sankpal, U. T., Maliakal, C., Baker, C. H., Safe, S. H., Herrera Garza, J. L., Abudayyeh, A., Kaja, S. & Basha, R., Jun 2012, In : Investigational New Drugs. 30, 3, p. 853-861 9 p.

    Research output: Contribution to journalArticle

  36. Human stanniocalcin-1 suppresses angiotensin II-induced superoxide generation in cardiomyocytes through UCP3-mediated anti-oxidant pathway

    Liu, D., Huang, L., Wang, Y., Wang, W., Wehrens, X. H. T., Belousova, T., Abdelrahim, M., Dimattia, G. & Sheikh-Hamad, D., May 31 2012, In : PLoS ONE. 7, 5, e36994.

    Research output: Contribution to journalArticle

  37. 2011
  38. Targeting Sp1 transcription factor in prostate cancer therapy

    Sankpal, U. T., Goodison, S., Abdelrahim, M. & Basha, R., Sep 2011, In : Medicinal Chemistry. 7, 5, p. 518-525 8 p.

    Research output: Contribution to journalReview article

  39. Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors

    Basha, R., Ingersoll, S. B., Sankpal, U. T., Ahmad, S., Baker, C. H., Edwards, J. R., Holloway, R. W., Kaja, S. & Abdelrahim, M., Jul 2011, In : Gynecologic Oncology. 122, 1, p. 163-170 8 p.

    Research output: Contribution to journalArticle

  40. Tolfenamic Acid Interrupts the De Novo Synthesis of the β-Amyloid Precursor Protein and Lowers Amyloid Beta Via a Transcriptional Pathway

    Adwan, L. I., Basha, R., Abdelrahim, M., Subaiea, G. M. & Zawia, N. H., Jun 2011, In : Current Alzheimer Research. 8, 4, p. 385-392 8 p.

    Research output: Contribution to journalArticle

  41. Methyl 2-cyano-3,12-dioxooleana-1, 9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: Role of microRNA-27a (Molecular Pharmacology (2010) 78, (226-236))

    Jutooru, I., Chadalapaka, G., Abdelrahim, M., Basha, M. R., Samudio, I., Konopleva, M., Andreeff, M. & Safe, S. H., Feb 2011, In : Molecular Pharmacology. 79, 2, p. 336 1 p.

    Research output: Contribution to journalComment/debate

  42. Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice

    Colon, J., Basha, M. R., Madero-Visbal, R., Konduri, S., Baker, C. H., Herrera, L. J., Safe, S., Sheikh-Hamad, D., Abudayyeh, A., Alvarado, B. & Abdelrahim, M., Feb 2011, In : Investigational New Drugs. 29, 1, p. 41-51 11 p.

    Research output: Contribution to journalArticle

  43. Therapeutic applications of NSAIDS in cancer: Special emphasis on tolfenamic acid

    Basha, R., Baker, C. T., Sankpal, U. T., Ahmad, S., Safe, S. H., Abbruzzese, J. L. & Abdelrahim, M., Jan 1 2011, In : Frontiers in Bioscience - Scholar. 3 S, 2, p. 797-805 9 p.

    Research output: Contribution to journalArticle

  44. 2010
  45. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth

    Lee, S. O., Abdelrahim, M., Yoon, K., Chintharlapalli, S., Papineni, S., Kim, K., Wang, H. & Safe, S., Sep 1 2010, In : Cancer Research. 70, 17, p. 6824-6836 13 p.

    Research output: Contribution to journalArticle

  46. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: Role of microRNA-27a

    Jutooru, I., Chadalapaka, G., Abdelrahim, M., Basha, M. R., Samudio, I., Konopleva, M., Andreeff, M. & Safe, S., Aug 2010, In : Molecular Pharmacology. 78, 2, p. 226-236 11 p.

    Research output: Contribution to journalArticle

  47. Role of peroxisome proliferator-activated receptor-γ and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia

    Tsao, T., Kornblau, S., Safe, S., Watt, J. C., Ruvolo, V., Chen, W., Qiu, Y., Coombes, K. R., Ju, Z., Abdelrahim, M., Schober, W., Ling, X., Kardassis, D., Meyer, C., Schimmer, A., Kantarjian, H., Andreeff, M. & Konopleva, M., Jun 15 2010, In : Cancer Research. 70, 12, p. 4949-4960 12 p.

    Research output: Contribution to journalArticle

  48. Activation of nerve growth factor-induced Bα by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth

    Cho, S. D., Lee, S. O., Chintharlapalli, S., Abdelrahim, M., Khan, S., Yoon, K., Kamat, A. M. & Safe, S., Mar 2010, In : Molecular Pharmacology. 77, 3, p. 396-404 9 p.

    Research output: Contribution to journalArticle

  49. The p38 MAPK pathway is critical for 5,5′-dibromodiindolylmethane- induced apoptosis to prevent oral squamous carcinoma cells

    Choi, K. H., Kim, H. K., Kim, J. H., Choi, E. S., Shin, J. A., Lee, S. O., Chintharlapalli, S., Safe, S., Abdelrahim, M., Kong, G., Choi, H. S., Jung, J. Y., Cho, H. T., Cho, N. P. & Cho, S. D., Mar 2010, In : European Journal of Cancer Prevention. 19, 2, p. 153-159 7 p.

    Research output: Contribution to journalArticle

  50. Angiogenesis: An update and potential drug approaches (Review)

    Abdelrahim, M., Konduri, S., Basha, M. R., Philip, P. A. & Baker, C. H., Jan 2010, In : International journal of oncology. 36, 1, p. 5-18 14 p.

    Research output: Contribution to journalReview article

  51. 2009
  52. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate in colon cancer cells

    Chintharlapalli, S., Papineni, S., Abdelrahim, M., Abudayyeh, A., Jutooru, I., Chadalapaka, G., Wu, F., Mertens-Talcott, S., Vanderlaag, K., Sung, D. C., Smith, R. & Safe, S., Oct 15 2009, In : International Journal of Cancer. 125, 8, p. 1965-1974 10 p.

    Research output: Contribution to journalArticle

  53. Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2

    Wang, Y., Huang, L., Abdelrahim, M., Cai, Q., Truong, A., Bick, R., Poindexter, B. & Sheikh-Hamad, D., Oct 2009, In : Journal of Leukocyte Biology. 86, 4, p. 981-988 8 p.

    Research output: Contribution to journalArticle

  54. The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression

    Liu, X., Abdelrahim, M., Abudayyeh, A., Lei, P. & Safe, S., May 1 2009, In : Molecular Cancer Therapeutics. 8, 5, p. 1207-1217 11 p.

    Research output: Contribution to journalArticle

  55. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression

    Konduri, S., Colon, J., Baker, C. H., Safe, S., Abbruzzese, J. L., Abudayyeh, A., Basha, M. R. & Abdelrahim, M., Mar 1 2009, In : Molecular Cancer Therapeutics. 8, 3, p. 533-542 10 p.

    Research output: Contribution to journalArticle

  56. Biomarkers clinical relevance in cancer: Emphasis on breast cancer and prostate cancer

    Basha, R., Baker, C. H. & Abdelrahim, M., 2009, In : Current Trends in Biotechnology and Pharmacy. 3, 1, p. 1-7 7 p.

    Research output: Contribution to journalReview article

  57. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met

    Papineni, S., Chintharlapalli, S., Abdelrahim, M., Lee, S. O., Burghardt, R., Abudayyeh, A., Baker, C., Herrera, L. & Safe, S., 2009, In : Carcinogenesis. 30, 7, p. 1193-1201 9 p.

    Research output: Contribution to journalArticle

  58. 2008
  59. Structure-dependent activation of endoplasmic reticulum stress_mediated apoptosis in pancreatic cancer by 1,1-bis(3′-indoly)-1-(p_substituted phenyl)methanes (Molecular Cancer Therapeutics (2008) 7, (3363-3372))

    Lei, P., Abdelrahim, M., Cho, S. D., Liu, X. & Safe, S., Nov 1 2008, In : Molecular Cancer Therapeutics. 7, 11, 1 p.

    Research output: Contribution to journalComment/debate

  60. Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3′-indoly)-1-(p-substituted phenyl)methanes

    Lei, P., Abdelrahim, M., Sung, D. C., Liu, X. & Safe, S., Oct 1 2008, In : Molecular Cancer Therapeutics. 7, 10, p. 3363-3372 10 p.

    Research output: Contribution to journalArticle

  61. 1,1-Bis (3′-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase

    Lei, P., Abdelrahim, M., Cho, S. D., Liu, S., Chintharlapalli, S. & Safe, S., Jun 2008, In : Carcinogenesis. 29, 6, p. 1139-1147 9 p.

    Research output: Contribution to journalArticle

  62. 1,1-Bis(3′-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells

    Cho, S. D., Lei, P., Abdelrahim, M., Yoon, K., Liu, S., Guo, J., Papineni, S., Chintharlapalli, S. & Safe, S., Apr 2008, In : Molecular Carcinogenesis. 47, 4, p. 252-263 12 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next

ID: 33110468